Antibiotic resistance of the most common bacteria isolated in blood cultures. Neonatal intensive care unit. Hospital III-1. Chiclayo, Perú 2020-2021
Descripción del Articulo
Introduccion: Bacterial resistance to antibiotics is associated with increased morbidity and mortality. Objective: Determine the antibiotic resistance of the most common bacteria isolated in blood cultures in a Neonatal Intensive Care Unit. Materials and methods: Descriptive – retrospective, the ide...
| Autores: | , |
|---|---|
| Formato: | artículo |
| Fecha de Publicación: | 2025 |
| Institución: | Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo |
| Repositorio: | Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo |
| Lenguaje: | español |
| OAI Identifier: | oai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/2425 |
| Enlace del recurso: | https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2425 |
| Nivel de acceso: | acceso abierto |
| Materia: | Resistencia a Antibióticos Hemocultivo Bacterias Unidad de Cuidado Intensivo Neonatal Antibiotic Resistance Blood Culture Bacteria Intensive Care Units, Neonatal |
| id |
REVCMH_3e6ae8bb8609ea611b3cf5d672a9fb35 |
|---|---|
| oai_identifier_str |
oai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/2425 |
| network_acronym_str |
REVCMH |
| network_name_str |
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
Antibiotic resistance of the most common bacteria isolated in blood cultures. Neonatal intensive care unit. Hospital III-1. Chiclayo, Perú 2020-2021 Resistencia antibiótica de bacterias más frecuentes aisladas en hemocultivos. Unidad de cuidados intensivos neonatal. Hospital III-1. Chiclayo, Perú 2020-2021 |
| title |
Antibiotic resistance of the most common bacteria isolated in blood cultures. Neonatal intensive care unit. Hospital III-1. Chiclayo, Perú 2020-2021 |
| spellingShingle |
Antibiotic resistance of the most common bacteria isolated in blood cultures. Neonatal intensive care unit. Hospital III-1. Chiclayo, Perú 2020-2021 Sosa-Flores, Jorge Luis Resistencia a Antibióticos Hemocultivo Bacterias Unidad de Cuidado Intensivo Neonatal Antibiotic Resistance Blood Culture Bacteria Intensive Care Units, Neonatal |
| title_short |
Antibiotic resistance of the most common bacteria isolated in blood cultures. Neonatal intensive care unit. Hospital III-1. Chiclayo, Perú 2020-2021 |
| title_full |
Antibiotic resistance of the most common bacteria isolated in blood cultures. Neonatal intensive care unit. Hospital III-1. Chiclayo, Perú 2020-2021 |
| title_fullStr |
Antibiotic resistance of the most common bacteria isolated in blood cultures. Neonatal intensive care unit. Hospital III-1. Chiclayo, Perú 2020-2021 |
| title_full_unstemmed |
Antibiotic resistance of the most common bacteria isolated in blood cultures. Neonatal intensive care unit. Hospital III-1. Chiclayo, Perú 2020-2021 |
| title_sort |
Antibiotic resistance of the most common bacteria isolated in blood cultures. Neonatal intensive care unit. Hospital III-1. Chiclayo, Perú 2020-2021 |
| dc.creator.none.fl_str_mv |
Sosa-Flores, Jorge Luis Chapoñan-Mendoza, Juan Fernando |
| author |
Sosa-Flores, Jorge Luis |
| author_facet |
Sosa-Flores, Jorge Luis Chapoñan-Mendoza, Juan Fernando |
| author_role |
author |
| author2 |
Chapoñan-Mendoza, Juan Fernando |
| author2_role |
author |
| dc.subject.none.fl_str_mv |
Resistencia a Antibióticos Hemocultivo Bacterias Unidad de Cuidado Intensivo Neonatal Antibiotic Resistance Blood Culture Bacteria Intensive Care Units, Neonatal |
| topic |
Resistencia a Antibióticos Hemocultivo Bacterias Unidad de Cuidado Intensivo Neonatal Antibiotic Resistance Blood Culture Bacteria Intensive Care Units, Neonatal |
| description |
Introduccion: Bacterial resistance to antibiotics is associated with increased morbidity and mortality. Objective: Determine the antibiotic resistance of the most common bacteria isolated in blood cultures in a Neonatal Intensive Care Unit. Materials and methods: Descriptive – retrospective, the identification of bacteria was done with VITEK XL, the susceptibility was done with the CLSI M100 guidelines. 30 edition. Results: The antibiotic resistance of the isolated bacteria was: Imipenem 15.6%, Meropenem 14.3%, Piperacillin/tazobactam 9.4%, Vancomycin 8.5%, Colistin 7.7%, Quinupristin/dalfopristin 7.1%, Amicacin 6.7%, Linezolid 2.7%. Tigecycline, Nitrofurantoin, Ertapenem, Tobramycin, Chloramphenicol, Streptomycin, Gentamicin had 0% resistance. The ECN had resistance to vancomycin 7.9%, Quinupristin/dalfopristin (6.4%), Linezolid (2.8%). Tigecycline, Nitrofurantoin, Doxycycline and Chloramphenicol had 0% resistance. Klebsiella pneumoniae: 0% resistance to Amicacin, meropenem, gentamicin, tigecycline, ertapenem, imepenem, colistin and piperazine/Tazobactan. Acinetobacter baumannii: 0% antibiotic resistance, for Gentamicin, Ciprofloxacin, Tigecycline, Colistin, Levofloxacin and Tobramycin. Conclusion: The antibiotics with 0% resistance to all bacteria were Tigecycline, Nitrofurantoin, Ertapenem, Doxycycline, Tobramycin, Chloramphenicol, Tobramycin, Chloramphenicol, Gentamicin. |
| publishDate |
2025 |
| dc.date.none.fl_str_mv |
2025-02-07 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Texto |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2425 10.35434/rcmhnaaa.2024.174.2425 |
| url |
https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2425 |
| identifier_str_mv |
10.35434/rcmhnaaa.2024.174.2425 |
| dc.language.none.fl_str_mv |
spa |
| language |
spa |
| dc.relation.none.fl_str_mv |
https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2425/965 |
| dc.rights.none.fl_str_mv |
Derechos de autor 2025 Jorge Luis Sosa-Flores, Juan Fernando Chapoñan-Mendoza https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
Derechos de autor 2025 Jorge Luis Sosa-Flores, Juan Fernando Chapoñan-Mendoza https://creativecommons.org/licenses/by/4.0 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo |
| publisher.none.fl_str_mv |
Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo |
| dc.source.none.fl_str_mv |
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 17 No. 4 (2024): Rev. Cuerpo Med. HNAAA, October - December; e2425 Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 17 Núm. 4 (2024): Rev. Cuerpo Med. HNAAA, Octubre - Diciembre; e2425 2227-4731 2225-5109 10.35434/rcmhnaaa.2024.174 reponame:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo instname:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo instacron:HNAAA |
| instname_str |
Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo |
| instacron_str |
HNAAA |
| institution |
HNAAA |
| reponame_str |
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo |
| collection |
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1852776607656181760 |
| spelling |
Antibiotic resistance of the most common bacteria isolated in blood cultures. Neonatal intensive care unit. Hospital III-1. Chiclayo, Perú 2020-2021Resistencia antibiótica de bacterias más frecuentes aisladas en hemocultivos. Unidad de cuidados intensivos neonatal. Hospital III-1. Chiclayo, Perú 2020-2021Sosa-Flores, Jorge LuisChapoñan-Mendoza, Juan FernandoResistencia a AntibióticosHemocultivoBacteriasUnidad de Cuidado Intensivo NeonatalAntibiotic ResistanceBlood CultureBacteriaIntensive Care Units, NeonatalIntroduccion: Bacterial resistance to antibiotics is associated with increased morbidity and mortality. Objective: Determine the antibiotic resistance of the most common bacteria isolated in blood cultures in a Neonatal Intensive Care Unit. Materials and methods: Descriptive – retrospective, the identification of bacteria was done with VITEK XL, the susceptibility was done with the CLSI M100 guidelines. 30 edition. Results: The antibiotic resistance of the isolated bacteria was: Imipenem 15.6%, Meropenem 14.3%, Piperacillin/tazobactam 9.4%, Vancomycin 8.5%, Colistin 7.7%, Quinupristin/dalfopristin 7.1%, Amicacin 6.7%, Linezolid 2.7%. Tigecycline, Nitrofurantoin, Ertapenem, Tobramycin, Chloramphenicol, Streptomycin, Gentamicin had 0% resistance. The ECN had resistance to vancomycin 7.9%, Quinupristin/dalfopristin (6.4%), Linezolid (2.8%). Tigecycline, Nitrofurantoin, Doxycycline and Chloramphenicol had 0% resistance. Klebsiella pneumoniae: 0% resistance to Amicacin, meropenem, gentamicin, tigecycline, ertapenem, imepenem, colistin and piperazine/Tazobactan. Acinetobacter baumannii: 0% antibiotic resistance, for Gentamicin, Ciprofloxacin, Tigecycline, Colistin, Levofloxacin and Tobramycin. Conclusion: The antibiotics with 0% resistance to all bacteria were Tigecycline, Nitrofurantoin, Ertapenem, Doxycycline, Tobramycin, Chloramphenicol, Tobramycin, Chloramphenicol, Gentamicin.Introducción: La resistencia bacteriana a los antibióticos, está asociada al incremento de morbilidad, mortalidad. Objetivo: Determinar la resistencia antibiótica de bacterias más frecuentes aisladas en hemocultivos, en una Unidad de cuidados intensivos neonatal. Materiales y métodos: descriptivo – retrospectivo, la identificación de bacterias, se hizo con VITEK XL, la susceptibilidad, con las pautas del CLSI M100. 30 edición. Resultados: La resistencia antibiótica de las bacterias aisladas, fue: Imipenem 15.6%, Meropenem 14.3%, Piperacilina/tazobactam 9.4%, Vancomicina 8.5%, Colistina 7.7%, Quinupristina/dalfopristina 7.1%, Amicacina 6.7%, Linezolid 2.7%. Tigeciclina, Nitrofurantoina, Ertapenem, Tobramicina, Cloranfenicol, Estreptomicina, Gentamicina tuvieron 0% de resistencia. El ECN, tuvo resistencia a vancomicina 7,9%, Quinupristina/dalfopristina (6,4%), Linezolid (2,8%). Tigeciclina, Nitrofurantoina, Doxiciclina y Cloranfenicol, tuvieron 0% de resistencia. Klebsiella pneumoniae: 0% resistencia para, Amicacina, meropenem, gentamicina, tigeciclina, ertapenem, imepenem, colistina y piperazina/Tazobactan. Acinetobacter baumannii: 0% resistencia antibiótica, para, Gentamicina, Ciprofloxacino, Tigeciclina, Colistina, Levofloxacino y Tobramicina. Conclusión: Los antibióticos con 0% de resistencia a todas las bacterias fueron, Tigeciclina, Nitrofurantoina, Ertapenem, Doxiciclina, Tobramicina, Cloranfenicol, Tobramicina, Cloranfenicol, Gentamicina.Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo2025-02-07info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTextoapplication/pdfhttps://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/242510.35434/rcmhnaaa.2024.174.2425Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 17 No. 4 (2024): Rev. Cuerpo Med. HNAAA, October - December; e2425Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 17 Núm. 4 (2024): Rev. Cuerpo Med. HNAAA, Octubre - Diciembre; e24252227-47312225-510910.35434/rcmhnaaa.2024.174reponame:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjoinstname:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjoinstacron:HNAAAspahttps://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2425/965Derechos de autor 2025 Jorge Luis Sosa-Flores, Juan Fernando Chapoñan-Mendozahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/24252025-05-19T04:52:26Z |
| score |
13.079393 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).